FindTrial
Sign In

An extension study of S-811717 (oxycodone hydrochloride solution for injection) in patients with cancer pain

An extension study of S-811717 (oxycodone hydrochloride solution for injection) in patients with cancer pain

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220762
Enrollment
Unknown
Registered
2009-06-30
Start date
2009-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesic for various cancers accompanied with moderate to severe pain

Interventions

investigational material(s) Generic name etc : S-811717 INN of investigational material : Opium alkaloid preparations (811) Therapeutic category code : 811 Opium alkaloids preparations Dosage and Admi

Sponsors

SHIONOGI & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inpatients with pain associated with various cancers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Safety, Efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026